Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.11
-0.26 (-4.84%)
Jan 2, 2026, 12:12 PM EST - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $908.88 million as of January 2, 2026. Its market cap has increased by 352.45% in one year.
Market Cap
908.88M
Enterprise Value
707.74M
1-Year Change
352.45%
Ranking
Category
Stock Price
$5.11
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $908.88M, an increase of 108.77%. That is a compound annual growth rate of 16.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |